Find AI Tools
Genesis Therapeutics logo

Genesis Therapeutics

Genesis Therapeutics is a biotech leader in molecular AI that unites deep learning and physics-based machine learning in its proprietary GEMS platform and Pearl foundation model to unlock tough protei

Try Genesis Therapeutics free
  • Free plan available
  • No credit card
Genesis Therapeutics screenshot

What is Genesis Therapeutics?

Genesis Therapeutics is a biotech company that uses artificial intelligence to discover new drug molecules. The company combines deep learning with physics-based machine learning through two proprietary tools: the GEMS platform and the Pearl foundation model. These tools are designed to predict how drug molecules interact with protein targets, then identify promising small-molecule candidates for development. The company works with pharmaceutical partners to apply its AI technology to their research programmes, whilst also developing its own pipeline of AI-discovered medicines. Genesis focuses on difficult protein targets that have traditionally been hard to drug, aiming to reduce the time and cost of early-stage drug discovery.

Key features

GEMS platform

Proprietary system that combines deep learning and physics-based machine learning for molecular prediction

Pearl foundation model

A trained AI model designed to understand and predict protein-ligand interactions

Protein-ligand prediction

AI-driven prediction of how drug molecules bind to and interact with target proteins

Small-molecule candidate identification

Automated discovery of potential drug candidates across disease areas

Pharma partnership capability

Integration with pharmaceutical companies' existing research pipelines

Pros & cons

Advantages

  • Addresses challenging protein targets that are difficult to drug using conventional methods
  • Combines multiple machine learning approaches rather than relying on a single technique
  • Backed by experienced biotech team with access to pharma partnerships and funding
  • Freemium model allows some access without upfront costs

Limitations

  • As an early-stage discovery tool, results still require validation through traditional wet-lab testing and clinical trials
  • Limited public information available about specific performance metrics or success rates compared to competitors
  • Intended primarily for pharmaceutical organisations rather than individual researchers or small teams

Use cases

Pharmaceutical companies screening potential drug candidates for hard-to-drug protein targets

Biotech firms accelerating their small-molecule discovery programmes

Academic research groups exploring protein-ligand interactions at scale

Drug development teams prioritising which molecules to synthesise and test first

Ready to try Genesis Therapeutics?

Try Genesis Therapeutics free

Pricing

Freemium

Free with limitations

Basic access to platform functionality with usage restrictions; paid or enterprise tiers available for greater capacity and features

Get started with Genesis Therapeutics

Click through to Genesis Therapeutics and start using it now.

Try Genesis Therapeutics free
  • Free plan available
  • No credit card